2017
DOI: 10.1007/s11936-017-0515-9
|View full text |Cite
|
Sign up to set email alerts
|

Dietary Self-management in Heart Failure: High Tech or High Touch?

Abstract: Dietary management of heart failure (HF) has largely been focused on sodium and fluid restrictions. Although safety and efficacy of these interventions in HF remain unclear, a daily sodium intake between 2000 and 3000 mg/day appears to be safe in these patients. Ongoing clinical research will inform on the safety and efficacy of a more restrictive sodium intake to less than 1500 mg/day. Data shows that routine fluid restriction in HF regardless of symptoms may be unnecessary; however, in patients with signs of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 71 publications
0
4
0
Order By: Relevance
“…Sodium is an essential nutrient and the primary cation in the extracellular fluid [ 22 , 23 ]. Previous study has shown that rats with high salt diet has higher sodium levels in the interstitial space [ 21 ].…”
Section: Resultsmentioning
confidence: 99%
“…Sodium is an essential nutrient and the primary cation in the extracellular fluid [ 22 , 23 ]. Previous study has shown that rats with high salt diet has higher sodium levels in the interstitial space [ 21 ].…”
Section: Resultsmentioning
confidence: 99%
“…It is considered pertinent to analyze that water restriction associated with sodium restriction may have influenced the findings. Limiting fluid intake to 1.5-2 L/day is advised only in severe Patients with HF with signs of congestion or hyponatremia (29) . Moreover, the benefits of this recommendation are controversial due to hemodynamic changes and progressive cardiac remodeling in chronic HF.…”
Section: Discussionmentioning
confidence: 99%
“…Yet, data are unclear as to the safety and efficacy of restricting fluids, with some evidence indicating routine restriction may be unwarranted unless IHF have pulmonary congestion or decompensated HF. 13,14 Comorbidities emerged as a new problem in managing HF treatment and symptoms. For example, different glucose-lowering agents affect HF outcomes, 15,16 while pulmonary disease, diabetes mellitus, and obesity tend to increase morbidity and mortality risk in both IHF with a preserved or reduced ejection fraction.…”
Section: Discussionmentioning
confidence: 99%